Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

US FDA explains reaccreditation of third party device reviewers; aligns with IMDRF

This article was originally published in Clinica

Executive Summary

The US FDA has issued a draft guideline on new requirements relating to the third party firms that the agency accredits to review medical device submissions, including an obligation for these firms to apply for reaccredition.